Articles by Stuart Bloor

Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective study

Verbiest, Werner; Brown, Stephen; Cohen, Calvin; More

AIDS. 15(5):647-650, March 30th, 2001.

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

Miller, Veronica; Sabin, Caroline; Hertogs, Kurt; More

AIDS. 14(18):2857-2867, December 22nd, 2000.

Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples

Hertogs, Kurt; Bloor, Stuart; Kemp, Sharon D.; More

AIDS. 14(9):1203-1210, June 16th, 2000.

Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel

Wegner, Scott A.; Brodine, Stephanie K.; Mascola, John R.; More

AIDS. 14(8):1009-1015, May 26th, 2000.

Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen

Casado, Jose L.; Hertogs, Kurt; Ruiz, Lidia; More

AIDS. 14(2):F1-F7, January 28th, 2000.

Baseline HIV drug resistance profile predicts response to ritonavir-saquinavir protease inhibitor therapy in a community setting

Harrigan, P. Richard; Hertogs, Kurt; Verbiest, Werner; More

AIDS. 13(14):1863-1871, October 1st, 1999.

The M184 V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors

Miller, Veronica; Stürmer, Martin; Staszewski, Schlomo; More

AIDS. 12(7):705-712, May 7th, 1998.